Concepedia

Publication | Open Access

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

DOIFull Paper Access

50

Citations

55

References

2021

Year

Graeme L. Fraser, Barbara Obermayer‐Pietsch, Joop S.E. Laven, Georg Griesinger, Axelle Pintiaux, D. Timmerman, Bart C.J.M. Fauser, Christopher Lademacher, Jean Combalbert, Hamid R. Hoveyda,
The Journal of Clinical Endocrinology & Metabolism

Abstract

Fezolinetant had a sustained effect to suppress hyperandrogenism and reduce the LH-to-FSH ratio in women with PCOS.

References

YearCitations

Page 1